Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > combretastatin

Combretastatin A4 Prodrug : OXiGENE : Angiogenesis inhibitor

Combretastatin (EurekAlert)
Press release announcing results of Phase I Combretastatin A4 phosphate trials trials in solid tumors. Results of the trial conducted by researchers at the University of Pennsylvania Cancer Center showed that patients with solid cancerous tumors were able to safely tolerate combretastatin. [4/00]


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 26-Apr-2011
Karen Parles, MLS Editor